10th Annual International Certificate Program

APRIL 8 – 14, 2018 | SIRACUSA, ITALY

(Registration opens in October 2017)

Stay tuned!

Overall Educational Objectives

Participants will:

  • Analyse the business, scientific and regulatory aspects of Translational Medicine (TM)
  • Explore the challenges professionals encounter in TM
  • Develop critical thinking skills to approach the challenges in TM
  • Develop communication skills for presenting complex scientific ideas to a broad spectrum of people
  • Analyse effective manuscript preparation and begin to apply the concepts to their own work

Here are some comments from the attendees:

“This really gave me a new insight into the process of translating medical discovery”
“Faculty as a whole combined expertise, ethusiasm and teaching talent”
This was an outstanding course”
“I am so glad I was given this opportunity, I am sure it will influence my thinking and career”
“Very rich experience!”
  • The concept and components of Translational Medicine
  • Intellectual property protection and development
  • Funding (public versus private)
  • Publication
  • Regulatory issues
  • Modelling diseases and therapies in experimental systems
  • From mountains to molehills: transforming basic research into leads
  • Research ethics
  • Data management and statistical strategies
  • Academia and industry partnerships
  • Clinical trial design
  • Managing research groups
  • International issues
  • Animal models
  • Refined approach: from global diseases to individualised care

2017 Curriculum

Name Designation
Salvatore Albani, M.D., Ph.D. Professor of Duke-NUS Medical School Singapore,
Director of SingHealth Translational Immunology and Inflammation Centre, UCAN-A Chair
Manuela Battaglia, Ph.D. Deputy Director San Raffaele Diabetes Research Institute – Milano (IT)
Wainwright Fishburn, J.D. Partner, Cooley LLP
Patricia Furlong, R.N., B.S., M.S. Founding President and Chief Executive Officer, Parent Project Muscular Dystrophy
Brian Goeltzenleuchter, MFA. Artist based in San Diego, USA
Carol Gregorio, Ph.D. Luxford/Schoolcraft Professor and Head of Cellular and Molecular Medicine; Co-Director, Sarver Heart Center; Director, Molecular Cardiovascular Research Program, The University of Arizona
David Hafler, M.D. Chief and Chair of Neurology, Yale New Haven Hospital and Yale School of Medicine
Janet Hafler, Ed.D. Professor of Pediatrics, Associate Dean for Educational Scholarship, Yale School of Medicine
Patrick Maxwell, M.D. Regius Professor of Physic and Head of the School of Clinical Medicine, University of Cambridge
Frank Miedema, Ph.D. Dean and Vice Chairman of the Board and professor of Immunology, University Medical Centre Utrecht, the Netherlands
Steven Hla Myint, M.D., Ph.D., MHSM Dip Clin, Dip MHS. Chairman, Inex Private Ltd, Singapore (Medtech)
Chairman, Plexpress Oy & Inc (Finland & USA) (Medtech)
Founding Partner, Innovatum Accelerator & Ukkopartners (IT and Biotech investments), Finland
General Partner, Pharma Capital (Biopharma Venture capitalism)
Senior Fellow & Strategic Consultant on commercialisation, A*star, Singapore (Government Research Agency)
Scientific Advisor, European Centre for Disease Control, Belgium
Martin Offringa, M.D., Ph.D. Senior Scientist and Program Head  Child Health Evaluative Sciences CHES, Research Institute, The Hospital for Sick Children, Staff Neonatologist, Department of Paediatrics, Professor of Paediatrics, University of Toronto
Berent Prakken, M.D., Ph.D. Professor of Pediatric Immunology, University Medical Centre Utrecht;
Chair Research and Education Division Pediatrics,
Co-Chair, UCAN-U; Chair, EUTRAIN
Sergio Quezada, Ph.D. Professorial Research Fellow and Group Leader at UCL Cancer Institute
Head, Immune Regulation and Rumor Immunotherapy Laboratory
Maria Grazia Roncarolo, M.D. George D. Smith Professor of Pediatrics and Medicine,
Division Chief, Pediatric Stem Cell Transplantation and Regenerative Medicine, Co-Director, Bass Center for Childhood Cancer and Blood Diseases,
Co-Director, Institute for Stem Cell Biology and Regenerative Medicine, Department of Pediatrics, Stanford School of Medicine
Norm Rosenblum, M.D. Professor of Paediatrics, Canada Research Chair in Developmental Nephrology, and Associate Dean, Physician Scientist Training, University of Toronto
George M. Rehm, J.D. Managing Partner and Managing Director
Aeris Capital AG
Alberto Risicato, M.D. Alberto Risicato, MD, Director of the Unit of Internal Medicine Hospital Muscatello.
Salmaan Sana Change Catalyst, Consultant and Programme Designer in Amsterdam, Netherlands
Vicki Seyfert-Margolis, Ph.D. CEO and Founder, My Own Med
Anita Small, M.Sc., Ed.D. Founder and owner of Small Language Connections
Anna van Suchtelen, M.A Visual artist
Nancy Sweitzer, M.D., Ph.D. Director, Sarver Heart Center,
Chief, Division of Cardiology,
University of Arizona College of Medicine
Uri Tabori, M.D. Staff NeuroOncologist, Division of Haematology/Oncology,
Associate Professor of Paediatrics, University of Toronto,
Senior Scientist, Research Institute and The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
Tim Triche, M.D., Ph.D. Professor, Pathology & Pediatrics
Keck School of Medicine at USC
C0-Director, Center for Personalized Medicine at CHLA
Lucy R Wedderburn, FRCP, Ph.D. Professor and Consultant of Paediatric Rheumatology, Director, Arthritis Research UK Centre for Adolescent Rheumatology at UCL , UCLH and GOSH, Deputy Director, NIHR Great Ormond Street Biomedical Research Centre, UCL GOS Institute of Child Health, University College London
Thorsten Vetter, M.D. Clinical Pharmacologist
Senior Scientific Officer – Scientific Advice
European Medicines Agency

Application for the 2017 program will opens from 1st October 2016.

Please submit online with the following on or before February 1st, 2017*:

•   CV (curriculum vitae)
•  Letter of support from your supervisor
• A brief statement of your needs and expectations of the course

*All required documents must be received in order by the stipulated deadline to be considered for attendance. All participant must commit to attend the full week course (including opening and closing dinner) and complete in advance the elearning requirement before course commences.

 Tuition*: €2500 + 22%VAT imposed under Italian law
(participants to bear all bank changes imposed)#

#The registration fee includes course materials, all lunches, breaks, and transportation from and to the Catania International Airport. Scholarships may be available. Please inquire.

Contact us at info@eurekainstitute.org if you have any questions about the program.